Tiger X Medical (OTCQB:CDOM) is the simplest and best risk/reward opportunity I have seen this year. The company is both tiny ($30 million market cap) and completely unknown. There are no articles on it, no press releases, and no blog posts. The company has neither quarterly conference calls nor a website. This complete lack of awareness in the investment community has created an excellent opportunity.
Though unknown, two savvy billionaires - Phillip Frost and Reinhold Schmieding - have taken an interest in Tiger X. Phillip Frost owns a 14.5% stake in the company. Reinhold Schmieding owns Tiger X's business partner, Arthrex.
The market has been ignoring extremely positive recent developments. Tiger X has traded roughly in the $0.08-$0.12...
Only subscribers can access this article, which is part of the PRO research library covering 3,574 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: